Olema Pharmaceuticals Inc (OLMA) — Strategic Asset Allocation Index
Olema Pharmaceuticals Inc (OLMA) has a Strategic Asset Allocation Index of 0.8% as of June 2023. Strategic assets (PP&E of $1.27 Million plus long-term investments of $-) total $1.27 Million, measured against net assets of $161.58 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check how tangible is Olema Pharmaceuticals Inc's equity to evaluate the tangible quality of the company's equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Olema Pharmaceuticals Inc Strategic Asset Allocation Index (2020–2022)
This chart shows how Olema Pharmaceuticals Inc's Strategic Asset Allocation Index has evolved across 3 annual periods from 2020 to 2022. As of June 2023, the index stands at 0.8%, representing strategic assets of $1.27 Million against net assets of $161.58 Million USD.
Annual Strategic Asset Allocation Index for Olema Pharmaceuticals Inc (2020–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Olema Pharmaceuticals Inc from 2020 to 2022, covering 3 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see market value of Olema Pharmaceuticals Inc.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 0.7% | $1.48 Million | $1.48 Million | $- | $197.55 Million | ▼ -0.9 pp |
| 2021 | 1.7% | $4.72 Million | $4.72 Million | $- | $284.57 Million | ▲ +1.6 pp |
| 2020 | 0.0% | $75.00K | $75.00K | $- | $338.14 Million | — |